Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.4 USD | +0.49% | +4.42% | +20.47% |
05:51pm | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
05:05pm | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,653 GBX | +0.76% | +3.38% | 83.75B | ||
148.8 DKK | +3.26% | +1.02% | 1.61B | ||
146.2 USD | -0.40% | -0.99% | 354B | ||
91.23 EUR | -0.43% | +4.99% | 123B | ||
2.744 USD | -0.59% | +5.93% | 22.4M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.47% | 331B | |
+26.20% | 653B | |
+27.00% | 556B | |
-6.57% | 354B | |
+2.57% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B | |
-11.58% | 143B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck and : Why the world needs more than one Ebola vaccine